Stuelpnagel John R

Avg. Two Year Performance

No purchase track record
(61%) Avg. Sale Return
(27%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(5%)(17%)(33%)(42%)(61%)
Sale Success Rate8 of 294 of 294 of 297 of 2911 of 29
Drugs » Biotechnology

Sr VP and COO, Director:

Holdings: 337.84K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: 344.25K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--